
Exact Sciences Corporation EXAS
Annual report 2025
added 02-13-2026
Exact Sciences Corporation Operating Cycle 2011-2026 | EXAS
Annual Operating Cycle Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.7 | 92.9 | 87.2 | 94.4 | 125 | 124 | 158 | 157 | 156 | 86.5 | 145 | 618 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 618 | 86.5 | 161 |
Quarterly Operating Cycle Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.9 | 99.5 | 109 | - | 89.6 | 88.3 | 92.9 | - | 98.8 | 101 | 96.3 | - | 51.9 | 53.6 | 113 | 122 | 121 | 122 | 131 | 130 | 141 | 187 | 134 | 120 | 162 | 170 | 157 | 123 | 155 | 174 | 167 | 129 | 148 | 174 | 121 | 45 | 51.2 | 61.8 | 68 | 79.5 | 117 | 175 | 183 | 108 | 824 | 427 | 214 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 824 | 45 | 144 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 18.56 | - | $ 196 M | ||
|
Agilent Technologies
A
|
161 | $ 113.26 | - | $ 34.4 B | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.63 | - | $ 2.17 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 18.88 | - | $ 547 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.19 | - | $ 490 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 20.49 | - | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 96.67 | - | $ 6.52 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 419.17 | - | $ 12.1 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 041.91 | - | $ 21.5 B | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 3.62 | - | $ 335 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
102 | $ 8.36 | - | $ 1.07 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.93 | - | $ 424 M | ||
|
Natera
NTRA
|
81.5 | $ 196.91 | - | $ 19.4 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 159.12 | - | $ 7.89 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 25.5 | - | $ 24.2 B | ||
|
Guardant Health
GH
|
128 | $ 98.66 | - | $ 12.4 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.82 | - | $ 243 M | ||
|
Personalis
PSNL
|
63.8 | $ 6.71 | - | $ 599 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 117.09 | - | $ 9.66 B | ||
|
Illumina
ILMN
|
198 | $ 143.24 | - | $ 22.8 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.99 | - | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
204 | $ 2.41 | - | $ 5.54 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 448.21 | - | $ 169 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 254.02 | - | $ 21.1 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.58 | - | $ 208 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 52.95 | - | $ 3.17 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 8.43 | - | $ 1.83 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 187.94 | - | $ 20.9 B |